NewLake Capital Partners Inc
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our Properties
We seek to acquire specialized real estate assets used for cultivation and processing of cannabis as well as retail dispensaries that are strategic profit centers for our tenants and are well positioned for the regulatory evolution of the industry. These licensed facilities are critical components of the cannabis industry, particularly in limited-license jurisdictions. As of December 31, 2024, we owned 32 properties comprised of 17 dispensaries and 15 cultivation facilities that are 100% leased to state-licensed cannabis operators, with a weighted average remaining lease term of 13.39 years. Based on invested capital, as of December 31, 2024, our portfolio is comprised of approximately 91.1% cultivation facilities and 8.9% dispensaries.
As of December 31, 2024, we have aggregate unfunded commitments to invest $11.0 million for the development and improvement of our existing cultivation facility in Connecticut. We define these improvement allowances as a commitment pursuant to our lease with the tenant to fund alterations, additions or improvements to the premises. Our leases are generally structured to disburse capital over specified periods of time. The leases also generally contain certain provisions that require tenants to pay rent on the full amount of capital under each lease, whether or not disbursed.
Existing Portfolio. The table below sets forth our property portfolio as of December 31, 2024 (in thousands, except square feet):
| Property Type · State · Tenant(1) · Rentable Square Feet(2) · Investment in Real Estate(3) · Real Estate Construction in Progress · Total Real Estate · In-Place Lease Intangible Assets(4) · Total Investment | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Cultivation | Florida | Curaleaf | 417,350 | $75,983 | $— | $75,983 | $— | $75,983 | |
| Cultivation | Illinois | Cresco Labs | 222,455 | 50,732 | — | 50,732 | — | 50,732 | |
| Cultivation | Massachusetts | Revolutionary Clinics, Inc. | 145,852 | 42,860 | — | 42,860 | — | 42,860 | (5) |
| Cultivation | Pennsylvania | Trulieve | 144,602 | 44,270 | — | 44,270 | 12,331 | 56,601 | |
| Cultivation | Arizona | Mint | 100,758 | 21,810 | — | 21,810 | — | 21,810 | |
| Cultivation | Pennsylvania | Calypso Enterprises | 99,200 | 31,007 | 1,006 | 32,013 | — | 32,013 | |
| Cultivation | Missouri | C3 Industries, Inc. | 94,570 | 29,017 | — | 29,017 | — | 29,017 | |
| Cultivation | Missouri | Organic Remedies | 81,808 | 21,101 | — | 21,101 | — | 21,101 | |
| Cultivation | Connecticut | C3 Industries, Inc. | 58,436 | 3,993 | 981 | 4,974 | — | 4,974 | |
| Cultivation | Nevada | AYR Wellness | 56,536 | 13,579 | — | 13,579 | — | 13,579 | |
| Cultivation | Massachusetts | The Cannabist Company | 38,890 | 13,826 | — | 13,826 | 4,120 | 17,946 | |
| Cultivation | Massachusetts | Acreage | 38,380 | 9,791 | — | 9,791 | — | 9,791 | |
| Cultivation | Pennsylvania | AYR Wellness | 38,031 | 15,278 | — | 15,278 | — | 15,278 | |
| Cultivation | Illinois | The Cannabist Company | 32,802 | 11,361 | — | 11,361 | 3,106 | 14,467 | |
| Cultivation | Pennsylvania | Acreage | 30,625 | 10,161 | — | 10,161 | — | 10,161 | |
| Dispensary | Connecticut | Curaleaf | 11,181 | 2,930 | — | 2,930 | 441 | 3,371 | |
| Dispensary | Massachusetts | PharmaCann | 11,116 | 2,112 | — | 2,112 | 363 | 2,475 | |
| Dispensary | Arkansas | Greenlight | 7,592 | 2,157 | — | 2,157 | 320 | 2,477 | |
| Dispensary | Ohio | Curaleaf | 7,200 | 3,353 | — | 3,353 | 582 | 3,935 | |
| Dispensary | Illinois | Curaleaf | 6,100 | 1,734 | — | 1,734 | 257 | 1,991 | |
| Dispensary | Illinois | Curaleaf | 5,040 | 3,362 | — | 3,362 | 575 | 3,937 | |
| Dispensary | Illinois | The Cannabist Company | 4,736 | 1,215 | — | 1,215 | 206 | 1,421 | |
| Dispensary | North Dakota | Curaleaf | 4,590 | 2,174 | — | 2,174 | 355 | 2,529 | |
| Dispensary | Massachusetts | The Cannabist Company | 4,290 | 2,320 | — | 2,320 | 373 | 2,693 | |
| Dispensary | Illinois | Curaleaf | 4,200 | 1,024 | — | 1,024 | 178 | 1,202 | |
| Dispensary | Ohio | PharmaCann | 3,735 | 1,550 | — | 1,550 | — | 1,550 | |
| Dispensary | Pennsylvania | Curaleaf | 3,500 | 2,226 | — | 2,226 | 369 | 2,595 | |
| Dispensary | Pennsylvania | PharmaCann | 3,481 | 1,315 | — | 1,315 | 256 | 1,571 | |
| Dispensary | Connecticut | Acreage | 2,872 | 929 | — | 929 | — | 929 | |
| Dispensary | California | The Cannabist Company | 2,470 | 3,774 | — | 3,774 | 1,071 | 4,845 | |
| Dispensary | Pennsylvania | Curaleaf | 1,968 | 1,918 | — | 1,918 | 320 | 2,238 | |
| Dispensary | Illinois | Curaleaf | 1,851 | 594 | — | 594 | 98 | 692 | |
| Total | 1,686,217 | $429,456 | $1,987 | $431,443 | $25,321 | $456,764 | |||
(1) Lease is with a subsidiary of this entity, for which this entity or an affiliate is a guarantor.
(2) Includes estimated rentable square feet at completion of construction.
(3) Includes the purchase price (and in some cases, transaction costs that have been capitalized into the purchase price) and building and improvement commitments funded, if any, as of December 31, 2024. Excludes building and improvement commitments not funded as of December 31, 2024.
(4) Represents gross In-Place Intangibles at acquisition. Does not include accumulated amortization.
(5) Includes approximately $40.0 million in cash and 88,200 OP Units issued in connection with the purchase of the property.
The following table sets forth a summary of the lease expirations for leases in place as of December 31, 2024 for each of the ten full calendar years beginning January 1, 2025. The information set forth in the table does not assume exercise of renewal options by tenants (square footage and annualized base rent in thousands).
| Year of Lease Expiration | Number of Leases Expiring | Square Footage of Leases Expiring | % of Portfolio Net Rentable Square Feet | Annualized Base Rent(1) | % of Portfolio Annualized Base Rent | Annualized Base Rent per Leased Square Foot(2) |
|---|---|---|---|---|---|---|
| 2025 | — | — | —% | $— | —% | $— |
| 2026 | — | — | —% | — | —% | — |
| 2027 | — | — | —% | — | —% | — |
| 2028 | — | — | —% | — | —% | — |
| 2029 | 3 | 11 | 0.7% | 878 | 1.7% | 76.33 |
| 2030 | — | — | —% | — | —% | — |
| 2031 | 2 | 15 | 0.9% | 411 | 0.8% | 28.13 |
| 2032 | 8 | 44 | 2.6% | 1,729 | 3.4% | 39.66 |
| 2033 | 2 | 10 | 0.6% | 585 | 1.1% | 60.77 |
| 2034 | 5 | 442 | 26.2% | 15,781 | 30.7% | 35.73 |
| Thereafter | 12 | 1,165 | 69.0% | 32,051 | 62.3% | 27.50 |
| Total/Weighted Average | 32 | 1,686 | 100.0% | $51,434 | 100.0% | $30.50 |
(1) Annualized base rent is calculated by multiplying (i) contractual rental income (including contractual rent from two non-performing tenants since the leases had not be modified as of December 31, 2024, and excluding reimbursable revenues) for the month ended December 31, 2024, by (ii) 12.
(2) Annualized base rent per leased square foot is calculated by dividing (i) annualized contractual base rent (including contractual rent from two non-performing tenants since the leases had not be modified as of December 31, 2024 and excluding reimbursable revenues) by (ii) net rentable square feet. Amounts may not recalculate due to rounding.
We target companies that have successfully navigated complex state regulation and fulfilled rigorous state-licensing requirements. We believe we have been diligent in partnering with a diverse tenant base of experienced operators in limited licensed jurisdictions that have strong management teams. Our tenants have generally demonstrated access to capital, which is critical to continuing to execute on their respective business plans.
As of December 31, 2024, all of our revenues were derived from 13 tenants. The following table sets forth the tenants in our property portfolio as of December 31, 2024 (dollars in thousands). All of our leases include a parent or other affiliate guarantee.
| Tenant(1) | Total Investment(2) | Number of Leases | Percentage of Annualized Rental Income(3) |
|---|---|---|---|
| Curaleaf | $98,474 | 10 | 22.8% |
| Cresco Labs | 50,732 | 1 | 12.9% |
| Trulieve | 56,601 | 1 | 11.0% |
| The Cannabist Company | 41,373 | 5 | 8.2% |
| C3 Industries | 33,990 | 2 | 7.5% |
| Calypso Enterprises | 32,013 | 1 | 7.1% |
| Acreage | 20,880 | 3 | 6.6% |
| Mint | 21,810 | 1 | 5.9% |
| Ayr Wellness | 28,857 | 2 | 5.8% |
| Revolutionary Clinics, Inc. | 42,860 | 1 | 5.7% |
| Organic Remedies | 21,101 | 1 | 4.8% |
| PharmaCann | 5,595 | 3 | 1.2% |
| Greenlight | 2,478 | 1 | 0.5% |
| Total | $456,764 | 32 | 100.0% |
(1) Lease may be with a subsidiary of this entity, for which this entity or an affiliate is a guarantor.
(2) Includes the purchase price (and in some cases, transaction costs that have been capitalized into the purchase price), gross In-Place Lease Intangible Assets and building and improvement commitments funded, if any, as of December 31, 2024. Excludes building and improvement commitments not funded as of December 31, 2024.
(3) Annualized Rental Income is calculated by multiplying (i) contractual rental income (including contractual rent from two non-performing tenants since the leases had not be modified as of December 31, 2024, and excluding reimbursable revenues) for the month ended December 31, 2024, by (ii) 12.
Curaleaf
We own nine dispensaries and one cultivation facility that are leased to subsidiaries of Curaleaf, which is, or an affiliate is, the corporate guarantor. Curaleaf is publicly-traded on the TSX and OTC markets under the symbols CURA and CURLF, respectively. Curaleaf’s filings, including their financial information, are electronically available at www.sec.gov and from the Canadian System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com, the Canadian equivalent of the SEC electronic document gathering and retrieval system.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.